Veraxa Biotech director files initial Form 3

Veraxa Biotech Holding AG director Marc Gruninger filed an initial Form 3, which is a statement of beneficial ownership for company insiders.

Rhea-AI Filing Summary

Veraxa Biotech Holding AG director Marc Gruninger filed an initial Form 3, which is a statement of beneficial ownership for company insiders. This filing does not list any stock transactions or holdings details; it simply establishes him as a reporting insider for future ownership and trading disclosures.

Key Terms

Form 3, beneficial ownership, reporting person

3 terms

Form 3 regulatory

"Marc Gruninger filed an initial Form 3, which is a statement of beneficial ownership"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

beneficial ownership financial

"Form 3, which is a statement of beneficial ownership for company insiders"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

reporting person regulatory

"It simply establishes him as a reporting insider for future ownership and trading disclosures"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Veraxa Biotech (VRXA) Form 3 filing for Marc Gruninger show?

The Form 3 shows that Marc Gruninger is a director and now an insider reporting person at Veraxa Biotech Holding AG. It is an initial ownership report and does not list any specific stock transactions or share amounts.

Are there any stock purchases or sales in the Veraxa Biotech (VRXA) Form 3?

No, this Form 3 contains no reported stock purchases, sales, or other transactions. It only identifies Marc Gruninger as a director and sets up his status for future insider ownership and trading disclosures with the SEC.

Why is Marc Gruninger listed as a reporting person for Veraxa Biotech (VRXA)?

Marc Gruninger is listed as a reporting person because he serves as a director at Veraxa Biotech Holding AG. Directors are considered insiders and must file Form 3 to begin formally reporting their beneficial ownership and future changes in their holdings.

Does the Veraxa Biotech (VRXA) Form 3 reveal Marc Gruninger’s share count?

The provided Form 3 data does not include any explicit share counts or holdings for Marc Gruninger. It functions as an initial registration of his insider status rather than a detailed statement of current ownership levels or recent transactions.

How does this Veraxa Biotech (VRXA) Form 3 affect investors?

This Form 3 mainly provides administrative transparency by identifying Marc Gruninger as an insider director. It does not report any trades or ownership changes, but it means future insider transactions by him will be reported on subsequent SEC forms.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/10/2026 - 09:42 AM EDT Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Gruninger Marc

(Last) (First) (Middle)

ST. ANNAGASSE 9

C/O VALFOR

(Street)

ZURICH 8021

(City) (State) (Zip)

SWITZERLAND

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
06/09/2026

3. Issuer Name and Ticker or Trading Symbol
Veraxa Biotech Holding AG [ VRXA ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ Marc Gruniger	06/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)